Veltassa and Dolutegravir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Veltassa (patiromer sorbitex calcium) and Dolutegravir (dolutegravir). Common drug interactions include hyperkalaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Veltassa and Dolutegravir. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Veltassa?
Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.
What is Dolutegravir?
Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.
11 people who take Veltassa and Dolutegravir together, and have interactions are studied.
What are the common drug interactions of Veltassa and Dolutegravir, by gender? *:
female:
n/a
male:
- Hyperkalaemia (damage to or disease of the kidney)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Drug ineffective
What are the common drug interactions of Veltassa and Dolutegravir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Hyperkalaemia (damage to or disease of the kidney)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Drug ineffective
What are the existing conditions these people have? *
- Hyperkalemia (damage to or disease of the kidney): 11 people, 100.00%
- Cardiac Failure: 10 people, 90.91%
* Approximation only. Some reports may have incomplete information.
Do you take Veltassa and Dolutegravir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Veltassa (15,649 reports)
- Dolutegravir (7,071 reports)
Browse all drug interactions of Veltassa and Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Veltassa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Dolutegravir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Veltassa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dolutegravir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on patiromer sorbitex calcium and dolutegravir (the active ingredients of Veltassa and Dolutegravir, respectively), and Veltassa and Dolutegravir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Enhertu cause Nosebleed? - 5 seconds ago
- Drug interactions of Augmentin and Ciclosporin - 6 seconds ago
- Drug interactions of Mobic and Midodrine Hydrochloride - 10 seconds ago
- Drug interactions of Opzelura and Folic Acid - 21 seconds ago
- Could Pantoprazole Sodium cause Rash Erythematous? - 23 seconds ago
- Drug interactions of Flexeril and Nizoral - 26 seconds ago
- Drug interactions of Vistaril and Arthrotec - 29 seconds ago
- Could Percocet cause Weight Fluctuation? - 33 seconds ago
- Could Albuterol cause Retinal Tear? - 39 seconds ago
- Drug interactions of Dexpanthenol and Estradiol - 40 seconds ago